AMPLIFY™ Technology Enhances Prenatal Screening for 22q11.2 Microdeletion
Myriad Genetics
APRIL 15, 2024
Typically, the way to diagnose 22q prenatally is through chorionic villus sampling or an amniocentesis. Less invasive options like prenatal cell-free DNA (cfDNA) screens can also be used to help identify the microdeletion. Thus, the value of using cfDNA screens for 22q has been marginal. Such is the case with the 22q11.2
52 
Let's personalize your content